Lucy Scientific Discovery Inc. (LSDI) Research

Lucy Scientific Discovery Inc. focuses on the entire lifecycle of psychedelic products, from their initial research and development to their production and subsequent market release. The company's offerings include fundamental biological raw materials, unprocessed extracts, a variety of psychotropic compounds, and critical active pharmaceutical ingredients (APIs). Established in 2017, this firm, formerly known as Hollyweed North Cannabis, Inc., is headquartered in Victoria, Canada.

Market snapshot

Symbol
LSDI
Price
$0.51
Day change
-23.29%
Market cap
$906.9K
P/E ratio
-0.73x
52-week range
0.44-12.8
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Acorda Therapeutics, Inc. (ACOR)
  • Accelerate Diagnostics, Inc. (AXDX)
  • Cyclo Therapeutics, Inc. (CYTH)
  • HTG Molecular Diagnostics, Inc. (HTGMQ)
  • Impel Pharmaceuticals Inc. (IMPL)
  • Neptune Wellness Solutions Inc. (NEPTF)
  • 9 Meters Biopharma, Inc. (NMTRQ)
  • InVivo Therapeutics Holdings Corporation (NVIV)

Recent insider activity

  • McElvany Christopher — C-Conversion (366187 shares) on 2023-02-13
  • McElvany Christopher — J-Other (118403 shares) on 2023-02-13
  • McElvany Christopher — C-Conversion (500000 shares) on 2023-02-13
  • Kazeminy Assad J — J-Other (85000 shares) on 2023-02-13
  • Susin Livio — J-Other (9309 shares) on 2023-02-13

Open Lucy Scientific Discovery Inc. (LSDI) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.